Skip to main content
CTS
NYSE Manufacturing

CTS Corp. Reports Strong Q1 Earnings, CEO Establishes Plan to Sell 130,000 Shares

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
7
Price
$56.13
Mkt Cap
$1.608B
52W Low
$36.025
52W High
$59.66
Market data snapshot near publication time

summarizeSummary

CTS Corp. reported strong Q1 2026 financial results, including a 10.7% increase in net sales and a 28.7% rise in net earnings, while its CEO established a plan to sell up to 130,000 shares.


check_boxKey Events

  • Strong Q1 2026 Financial Performance

    Net sales increased 10.7% to $139.23 million, and net earnings rose 28.7% to $17.20 million, resulting in diluted EPS of $0.59 for the quarter ended March 31, 2026.

  • CEO Establishes 10b5-1 Selling Plan

    President and CEO Kieran M. O'Sullivan entered into a Rule 10b5-1 Plan on March 2, 2026, for the sale of up to 130,000 shares of common stock, scheduled to terminate by February 25, 2028.

  • Environmental Liability Settlement Reached

    The company agreed in principle to a $7.61 million settlement for the Asheville Site EPA claim, with its portion estimated at $6.67 million, recorded as of March 31, 2026.

  • Continued Share Repurchase Activity

    During Q1 2026, CTS Corp. repurchased 176,909 shares of common stock for $8.64 million under its $100 million 2025 repurchase program, with $81.72 million remaining available.


auto_awesomeAnalysis

This 10-Q filing confirms CTS Corp.'s strong first-quarter financial performance, with double-digit growth in net sales and diluted EPS, largely aligning with expectations set by prior 8-K announcements. However, the disclosure of the CEO's new 10b5-1 plan to sell a substantial number of shares introduces a notable negative signal, which could temper the positive sentiment from the operational results. The agreement in principle for a significant environmental settlement resolves a long-standing contingency, reducing future uncertainty, and the company continued its share repurchase program, returning capital to shareholders. Investors should weigh the positive financial results and liability resolution against the insider selling activity.

At the time of this filing, CTS was trading at $56.13 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $36.03 to $59.66. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CTS - Latest Insights

CTS
Apr 29, 2026, 12:40 PM EDT
Filing Type: 10-Q
Importance Score:
7
CTS
Apr 29, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
7
CTS
Apr 29, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
CTS
Feb 10, 2026, 8:01 AM EST
Filing Type: 8-K
Importance Score:
8
CTS
Feb 10, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
8